β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH) Chemical Properties

form 

Solid

color 

Light yellow to yellow

InChI

InChI=1/C11H17N2O8P.Na.H/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19;;/h1,3-4,7-9,11,14-15H,2,5H2,(H2,12,16)(H2,17,18,19);;/t7-,8-,9-,11-;;/s3

InChIKey

LSKSZICSFLRXJW-RAJFINMANA-N

SMILES

O[C@@H]1[C@@H]([C@@H](COP(O)(O)=O)O[C@H]1N1C=CCC(C(=O)N)=C1)O.[NaH] |&1:1,2,3,11,r|

β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH) Usage And Synthesis

Description

NMNH (reduced Nicotinamide Mononucleotide) is a new potent NAD+ precursor. It is a new form of NMN, can increase NAD levels to a much higher extent.
NMNH is a fluorescent molecule, in contrast to NMN. The molecular formulae for NMNH is C11H17N2O8P and it is also known as 1-(5-O-phosphono-beta-D-ribofuranosyl) -1,4-dihydropyridine-3-carboxamide Reduced nicotinamide mononucleotide.

Uses

β-Nicotinamide mononucleotide (NMNH), reduced form disodium (β-NMN) is the oxidized form of NAD+ precursor and is a NAD+ enhancer. β-Nicotinamide mononucleotide, reduced form disodium can be reduced to dihydronicotinamide mononucleotide (NMNH). NMNH inhibits glycolysis, TCA cycle, and cell growth[1].

General Description

β-Nicotinamide mononucleotide, reduced form disodium (β-NMN) is the oxidized form of NAD+ precursor and is a NAD+ enhancer. β-Nicotinamide mononucleotide, reduced form disodium can be reduced to dihydronicotinamide mononucleotide (NMNH). NMNH inhibits glycolysis, TCA cycle, and cell growth.

storage

2-8°C

References

[1] Liu Y, et al. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. J Proteome Res. 2021 May 7;20(5):2596-2606. DOI:10.1021/acs.jproteome.0c01037

β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH)(108347-85-9)Related Product Information

• β-Nicotinamide Mononucleotide
• 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride
• NAD+
• Nicotinamide riboside chloride